CHICAGO, IL and Minneapolis, MN - July 22, 1999
Cargill, Inc. and Integrated Genomics, Inc. announced today a research and licensing agreement in the area of genomics of industrial microorganisms. Under the terms of the agreement, Integrated Genomics will sequence and analyze the genomes of microbial strains of interest to Cargill. Cargill will also license Integrated Genomics' bioinformatics tools, including the WIT-PRO™ genome analysis suite and biochemical and genomic databases.
"Cargill is pleased to be working with Integrated Genomics on the genomics of industrial microorganisms," said Dr. Douglas C. Cameron, director of Biotechnology in Cargill's Central Research Department.
"This agreement with one of the leaders in the life science industry is very encouraging", said Robert Haselkorn, President and Chairman of Integrated Genomics. "Cargill's acceptance of our genomics-based approach to strain improvement proves its value in the world of industrial microbiology. We expect to provide much more than DNA sequences, including genome-based reconstruction of cell metabolism."
Cargill, Inc., based in Minneapolis, MN, is an international marketer, processor and distributor of agricultural, food, financial and industrial products with some 79,000 employees in more than 1,000 locations in 72 countries and with business activities in 100 more.
About Integrated Genomics
Integrated Genomics Inc., based in Chicago, Illinois, offers a systematic approach to solving industrial problems, such as strain and fermentation improvement, by using proprietary methods of genome analysis, metabolic modeling and design. The company specializes in bacterial and fungal genomics.
Dr. Robert Haselkorn
Integrated Genomics, Inc.